Sign in

Keros Therapeutics, Inc.

Income Statement - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.24 0.00 0.00 0.02 0.02 0.00 0.01 0.01
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01
Gross profit 0.24 0.00 0.00 0.00 0.02 0.00 -0.01 0.00
Total operating expenses + 0.17 0.21 0.17 0.11 0.08 0.05 0.02 0.01
Operating income 0.07 -0.21 -0.17 -0.11 -0.06 -0.05 -0.01 0.00
Non-operating income (net) 0.02 0.02 0.02 0.01 0.00 0.00 0.00 0.00
Income before tax 0.09 -0.19 -0.15 -0.10 -0.06 -0.05 -0.01 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income 0.09 -0.19 -0.15 -0.10 -0.06 -0.05 -0.01 0.00
Show Quarterly Income Statement

Income Statement - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total revenue 0.00 0.00 0.01 0.02 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.01 0.02 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 -0.01 0.00 -0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00
Total operating expenses + 0.03 0.03 0.03 0.06 0.06 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01
Operating income -0.03 -0.03 -0.02 -0.04 0.15 -0.05 -0.06 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 0.00 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.02 -0.01 -0.03 0.16 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.02 -0.03 -0.02 0.00 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.02 -0.02 -0.01 -0.03 0.15 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.02 -0.03 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
5 days ago

Balance Sheet - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.29 0.56 0.33 0.28 0.23 0.27 0.01 0.02
Accounts receivable, net 0.01 0.00 0.00 0.00 0.02 0.00 0.00
Inventories 0.01 0.00 0.00 0.00 0.00
Other current assets 0.02 0.02 0.02 0.01 0.00 0.00 0.00 0.00
Total current assets 0.32 0.59 0.35 0.29 0.25 0.27 0.01 0.03
Total non-current assets + 0.02 0.03 0.02 0.02 0.00 0.00 0.00 0.00
Total assets 0.34 0.62 0.37 0.31 0.26 0.27 0.01 0.03
Total current liabilities + 0.02 0.03 0.02 0.02 0.01 0.01 0.00 0.01
Total non-current liabilities + 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00
Total liabilities 0.03 0.04 0.04 0.03 0.01 0.01 0.01 0.01
Total stockholders' equity + 0.30 0.57 0.33 0.28 0.24 0.26 0.01 0.01
Common shares outstanding 38 37 29 25 23 16 9 9
Show Quarterly Balance Sheet

Balance Sheet - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total cash and short-term investments + 0.28 0.29 0.69 0.69 0.72 0.56 0.53 0.41 0.44 0.33 0.29 0.32 0.35 0.28 0.24 0.22 0.23 0.23 0.22 0.24 0.26 0.27 0.13 0.14 0.05 0.01 0.00 0.00 0.02
Accounts receivable, net 0.00 0.01 0.01 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.01 0.02 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.29 0.32 0.72 0.73 0.76 0.59 0.55 0.43 0.46 0.35 0.30 0.33 0.36 0.29 0.25 0.22 0.23 0.25 0.23 0.24 0.26 0.27 0.14 0.15 0.06 0.01 0.02
Total non-current assets + 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.02
Total assets 0.31 0.34 0.74 0.76 0.78 0.62 0.58 0.46 0.49 0.37 0.33 0.36 0.38 0.31 0.25 0.23 0.24 0.26 0.23 0.24 0.26 0.27 0.14 0.15 0.06 0.01
Total current liabilities + 0.01 0.02 0.02 0.03 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Total non-current liabilities + 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.01
Total liabilities 0.03 0.03 0.04 0.05 0.06 0.04 0.05 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.09 0.01
Total stockholders' equity + 0.29 0.30 0.70 0.71 0.73 0.57 0.53 0.42 0.45 0.33 0.30 0.33 0.35 0.28 0.24 0.21 0.22 0.24 0.22 0.24 0.25 0.26 0.13 0.14 -0.02 0.00 0.01
Common shares outstanding 38 38 41 41 41 40 36 36 29 30 30 30 28 27 26 24 24 23 23 23 23 22 20 18 18 9 9 9 9
5 days ago

Cash Flow - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + 0.11 -0.16 -0.12 -0.07 -0.06 -0.04 -0.02 0.01
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + -0.38 0.39 0.18 0.12 0.03 0.30 0.00 0.01
Change in cash -0.27 0.23 0.05 0.05 -0.03 0.26 -0.02 0.02
Show Quarterly Cash Flow

Cash Flow - Keros Therapeutics, Inc. (KROS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Operating cash flow + 0.00 -0.03 0.00 -0.03 0.16 -0.05 -0.03 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 0.00 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 0.00
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 -0.38 0.00 0.00 0.00 0.08 0.16 0.00 0.16 0.07 0.00 0.00 0.11 0.06 0.05 0.01 0.00 0.03 0.00 0.00 0.00 0.14 0.00 0.10 0.06 0.00 0.00 0.00 0.00
Change in cash -0.01 -0.41 0.00 -0.03 0.16 0.03 0.13 -0.04 0.11 0.04 -0.03 -0.03 0.07 0.04 0.02 -0.01 0.00 0.01 -0.01 -0.02 -0.01 0.13 -0.01 0.09 0.05 -0.01 0.00 -0.01 0.00
5 days ago

Keros Therapeutics, Inc. (KROS) - Income Before Tax

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Depreciation And Amortization

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Operating Expenses

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Research And Development

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Selling General And Administrative

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Operating Income

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Costof Goods And Services Sold

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Cost Of Revenue

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Total Revenue

1Y 2Y 5Y Max
10 days ago

Keros Therapeutics, Inc. (KROS) - Gross Profit

1Y 2Y 5Y Max
10 days ago